Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00096278 · OUTCOME

Disease-free Survival

Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer · Source last updated 2019-07-30

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of patients
Interval / dispersion
Not reported
Time frame
3 years

What was measured

Where events are defined as recurrence, second primary cancer, or death from any cause

Groups in this outcome

Arm 1: Oxaliplatin + Leucovorin + 5-Fluorouracil

Oxaliplatin + Leucovorin + 5-Fluorouracil

Arm 2: Oxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab

Oxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Arm 1: Oxaliplatin + Leucovorin + 5-Fluorouracil1338
Arm 2: Oxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab1334

Reported measurements

Source class 1
Values in percentage of patients · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm 1: Oxaliplatin + Leucovorin + 5-Fluorouracil75.5Not reportedNot reportedNot reportedNot reported
Arm 2: Oxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab77.4Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        75.5
      2. group Id
        OG001
        value
        77.4
denoms
  1. counts
    1. group Id
      OG000
      value
      1338
    2. group Id
      OG001
      value
      1334
    units
    Participants
description
Where events are defined as recurrence, second primary cancer, or death from any cause
groups
  1. description
    Oxaliplatin + Leucovorin + 5-Fluorouracil
    id
    OG000
    title
    Arm 1: Oxaliplatin + Leucovorin + 5-Fluorouracil
  2. description
    Oxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab
    id
    OG001
    title
    Arm 2: Oxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab
param Type
NUMBER
reporting Status
POSTED
time Frame
3 years
title
Disease-free Survival
type
PRIMARY
unit Of Measure
percentage of patients

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice